BioSig – Medical Device Maker Is Revolutionizing How Arrhythmias Are Treated

Ken Londoner, CEO of BioSig Technologies (NASDAQ: BSGM), was recently a guest on Benzinga’s All-Access

BioSig is a digital signal processing company that has created the PURE EP Platform. The company unites expertise in medical engineering, intellectual property and workflow to deliver intracardiac signals with unprecedented precision.

Its technology provides what it says is a new level of clarity and resolution in arrhythmia identification and visualization, empowering physicians with actionable insights.

Biosig has been working with the Cleveland Clinic – one of the foremost cardiology hospitals in the world – for close to a year now.

Watch here:

Featured photo by Nicola Fioravanti on Unsplash.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.